BeyondSpring Pharmaceuticals is a global clinical- stage biopharmaceutial company located in New York. The company develops innovative immuno-oncology cancer therapies with a robust pipeline from internal development and collaboration with the University of Washington in de novo drug discovery using an ubiquitination platform. Since 2010, Beyond Spring Pharmaceuticals has been on a mission to develop transformative cancer therapies that improve clinical outcomes for patients with high unmet needs.